Suppr超能文献

[三联双相化疗治疗小细胞支气管癌]

[Triple biphasic chemotherapy in the treatment of small-cell bronchial cancer].

作者信息

Briancon S, Thisse J Y, Watrin H, Feintrenie X, Lamaze R, Lamy P

出版信息

Presse Med. 1983 Dec 3;12(44):2805-8.

PMID:6318213
Abstract

Forty-three patients with small-cell bronchial carcinoma were treated with sequential combination chemotherapy of the CMC-VAP type alternating every 6 weeks. Toxicity affected mostly blood cells and occurred during induction. The response rate was 60% in circumscribed forms with a median survival of 15 months, and 30% in diffuse forms with a median survival of 6 months. The value of alternating protocols and the place of radiotherapy are discussed in the light of these results.

摘要

43例小细胞支气管癌患者接受了每6周交替进行的CMC-VAP型序贯联合化疗。毒性主要影响血细胞,且发生在诱导期。局限性病变的缓解率为60%,中位生存期为15个月;弥漫性病变的缓解率为30%,中位生存期为6个月。根据这些结果对交替方案的价值和放疗的地位进行了讨论。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验